Immunome Soars 15% as Phase 3 Trial of Desmoid Tumor Drug Achieves Overwhelming Success Dec 15, 2025 Life Science
A “Price-for-Tariffs” Deal: Could the UK’s Pact with the US Become Europe’s Template? Dec 2, 2025 Life Science
Regeneron Soars 5%: Can an Old Blockbuster Drug’s New Chapter Restore Investor Confidence? Dec 1, 2025 Life Science
Vertex Pharmaceuticals: A Diversification Play Poised to Join the Top 10 Global Healthcare Giants Nov 27, 2025 Life Science
